Speaker Profile
Sr. Director Precision Medicine, BMS
Biography
Jonathan Beer specializing in precision medicine and translational sciences. In this role, he leads diagnostic strategies and the development of companion diagnostics (CDx) for global investigational new drug clinical trials across various technologies and sample types including liquid biopsy. His expertise encompasses clinical trial applications and demonstrating clinical utility, with a focus on minimal residual disease (MRD) and multi-cancer early detection (MCED) through circulating tumor DNA (ctDNA) approaches. Jonathan's work is pivotal in advancing diagnostic strategies that support innovative therapies in oncology for BMS.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Adrian Lee, UPMC
- PMWC Award Ceremony
Pioneer Honoree: Victor Velculescu, Johns Hopkins
Luminary Honoree: Nicola Aceto, ETH Zurich
- Keynote: Early Detection of Cancer using Cell-free DNA Fragmentomes
- Victor Velculescu, Johns Hopkins - Keynote: The Power of a Blood Sample: Predictive Diagnostics and Transforming Healthcare
- Matthew Rabinowitz, Natera - Improving Sensitivity of MRD and MCED - Tumor-agnostic vs. Tumor-informed ctDNA Approaches
Chair: Adrian Lee, University of Pittsburgh
- Marija Balic, UPMC
- Ola Carl Landgren, University of Miami
- Carl Barrett, Precede Biosciences
- Jonathan Beer, BMS
- Innovative Approaches in Liquid Biopsy
Chair: Victor Velculescu, Johns Hopkins
- Adam Widman, MSKCC
- Brian Hashemi, Novigenix
- Sequencing Accuracy in Early Detection and MRD (PANEL)
Chair: Alex Sockell, PacBio
- James Hadfield, AstraZeneca
- Keynote: Keynote: Circulating Tumor Cells
- Nicola Aceto, ETH Zurich - Circulating Tumor Cells: The New Frontier
Chair: Nicola Aceto, ETH Zurich
- Min Yu, University of Maryland School of Medicine
- Matteo Ligorio, UTSW - Precision Liquid Biopsies: Innovations Across the Cancer Continuum – From Early Detection to Long-Term Monitoring
Chair: Tom Beer, Exact Sciences
- Elizabeth (Betsy) O’Donnell, Dana Farber Cancer Institute
- Arnaud Papin, Merck
- PMWC Showcase
- Wendy Winckler, Droplet Biosciences - Multi-Cancer Early Detection: Innovations and Real-World Evidence (PANEL)
Chair: Peter Bach, Delfi Dx
- Joshua Cohen, Haystack
- Lauren Leiman, BLOODPAC
- Eric Klein, Grail Bio
- Tom Beer, Exact Sciences - PMWC Showcase
- Varsha Rao, Claret Bio - PMWC Award Ceremony and Keynote
Luminary Honoree: Matthew Rabinowitz, Natera
